<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/prld" ></link>
<id>urn:uuid:f1a9ffd7-7d2b-3b0c-e557-048d467fbbd8</id>
<updated>2026-04-30T10:17:00-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>PRLD: RA CAPITAL MANAGEMENT L P (BO) Disposed (JS) 1.4mm Shares of PRELUDE THERAPEUTICS INC for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6391597" ></link>
<id>urn:uuid:5b03c66f-e517-69a0-a511-67222b74e417</id>
<updated>2026-04-28T17:14:55-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: RA CAPITAL MANAGEMENT L P (BO) Filed a Form 3, Becoming a Registered Insider at PRELUDE THERAPEUTICS INC With Initial Indirect Holdings of 7.9mm</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6391591" ></link>
<id>urn:uuid:7aea11b2-78f4-8403-4ad7-37ef0e46004d</id>
<updated>2026-04-28T17:13:28-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: BONITA DAVID P (DIR,BO) Bought (JB*) 2.8mm Shares of PRELUDE THERAPEUTICS INC for $4.44 on 4/21</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6390144" ></link>
<id>urn:uuid:bfecbcc1-27f3-f433-5699-8d6b95b78cbc</id>
<updated>2026-04-23T18:50:38-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: ORBIMED ADVISORS LLC (DIR,BO) Bought (JB*) 2.8mm Shares of PRELUDE THERAPEUTICS INC for $4.44 on 4/21</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6390140" ></link>
<id>urn:uuid:73f1d20a-bbe7-68cf-180d-1a6c0133d1d5</id>
<updated>2026-04-23T18:48:25-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: MORRIS CHARLES Q (O) Filed a Form 3, Becoming a Registered Insider at PRELUDE THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6386538" ></link>
<id>urn:uuid:f5640bcc-cf1c-e4e9-8965-e661cb207274</id>
<updated>2026-04-15T16:19:58-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: BRUSKY SEAN P (O) Filed a Form 3, Becoming a Registered Insider at PRELUDE THERAPEUTICS INC With Initial Direct Holdings of 100k</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6370262" ></link>
<id>urn:uuid:257c84d6-9e48-0a13-e9a9-2a280ea3aed7</id>
<updated>2026-03-19T19:39:30-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: DORTON KATINA (DIR) Filed a Form 3, Becoming a Registered Insider at PRELUDE THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6267108" ></link>
<id>urn:uuid:7237e74e-a149-46f6-c307-40dcf9e42dcd</id>
<updated>2025-10-20T16:01:15-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: HUANG JANE (PR,SO) Acquired (JB) 9,375 Shares of PRELUDE THERAPEUTICS INC for $0.00 on 10/4</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6263739" ></link>
<id>urn:uuid:8ce6e5bd-61c4-44dd-0851-373a8f843e23</id>
<updated>2025-10-07T07:05:37-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: HUANG JANE (PR,SO) Disposed (JS) 3,355 Shares of PRELUDE THERAPEUTICS INC for $1.47 on 10/4</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6263740" ></link>
<id>urn:uuid:d62f7301-0eb5-dd7d-bb8f-3b023125ffa6</id>
<updated>2025-10-07T07:05:37-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
<entry>
<title>PRLD: HUANG JANE (PR,SO) Acquired (JB) 9,375 Shares of PRELUDE THERAPEUTICS INC for $0.00 on 7/4</title>
<link href="http://www.insiderinsights.com/company/prld/prelude-therapeutics-inc/id-6227366" ></link>
<id>urn:uuid:442c4453-4b02-32c6-8676-201c411f987b</id>
<updated>2025-07-08T16:06:56-04:00</updated>
<summary type="html" ><![CDATA[PRELUDE THERAPEUTICS INC (PRLD). Recent Price: $4.64. Mkt Cap:291.7mm. 10D Vol: 513,679]]></summary>
</entry>
</feed>